Advertisement

Table of Contents

March 01, 1989; Volume 35,Issue 3

You have access
Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain.
E J Nestler, R Z Terwilliger and E Halm

Molecular Pharmacology March 1989, 35 (3) 265-270;
You have access
Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
P M Politi and B K Sinha

Molecular Pharmacology March 1989, 35 (3) 271-278;
You have access
Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian

Molecular Pharmacology March 1989, 35 (3) 279-285;
You have access
Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo

Molecular Pharmacology March 1989, 35 (3) 286-294;
You have access
Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen

Molecular Pharmacology March 1989, 35 (3) 295-303;
You have access
Beta-adrenergic desensitization reduces the sensitivity of adenylate cyclase for magnesium in permeabilized lymphocytes.
R D Feldman

Molecular Pharmacology March 1989, 35 (3) 304-310;
You have access
Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation.
M Mitsuhashi and D G Payan

Molecular Pharmacology March 1989, 35 (3) 311-318;
You have access
The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
Y Yao, A B Peter, R Baur and E Sigel

Molecular Pharmacology March 1989, 35 (3) 319-323;
You have access
[3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel

Molecular Pharmacology March 1989, 35 (3) 324-330;
You have access
Detection of nerve growth factor and epidermal growth factor-regulated protein kinases in PC12 cells with synthetic peptide substrates.
L E Heasley and G L Johnson

Molecular Pharmacology March 1989, 35 (3) 331-338;
You have access
Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
G Guillemette, S Lamontagne, G Boulay and B Mouillac

Molecular Pharmacology March 1989, 35 (3) 339-344;
You have access
Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
H Paris, J Galitzky and J M Senard

Molecular Pharmacology March 1989, 35 (3) 345-354;
You have access
The relationship between inositol trisphosphate receptor density and calcium release in brain microsomes.
S K Joseph and H L Rice

Molecular Pharmacology March 1989, 35 (3) 355-359;
You have access
N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
T A Verdoorn, N W Kleckner and R Dingledine

Molecular Pharmacology March 1989, 35 (3) 360-368;
You have access
Release of nonmitochondrial sequestered Ca2+ from permeabilized muscle cells in culture.
S K Ambler and P Taylor

Molecular Pharmacology March 1989, 35 (3) 369-374;
You have access
Ketanserin reduces a particular monoamine pool in peripheral tissues.
J E Leysen, J Wynants, A Eens and P A Janssen

Molecular Pharmacology March 1989, 35 (3) 375-380;
You have access
Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
C J Smith and V C Manganiello

Molecular Pharmacology March 1989, 35 (3) 381-386;